DUBLIN, June 7, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Intrathecal Pumps Market 2016-2020" report to their offering.
The report forecasts the global intrathecal pumps market to grow at a CAGR of 4.27% during the period 2016-2020.
An important trend which will have a big impact on market growth is the expanding application of intathecal pumps and the ability to customize medication doses. There has been a growing usage of intrathecal pumps worldwide. The use of intrathecal medication has emerged as a feasible option for the long-term treatment of cancer-related pain. The use of this therapy has grown significantly for chronic non-cancer pain, particularly for the treatment of chronic back pain. The therapy was most commonly preferred over traditional treatment due to its effectiveness, affordability, and better results. The positive results of insulin pumps have become popular among the pain population and is gaining increased acceptance to treat chronic pain.
A key growth driver is the favorable response from insurance companies. The healthcare insurance programs such as Medicare are driving the market. Several indications for treatment using infusion pumps are covered under this program. Morphine infusion through an external infusion pump is covered when used in the treatment of intractable pain due to cancer (in an inpatient or outpatient setting, including a hospice).
An implantable infusion pump is covered under this program when used to administer anti-spasmodic drugs such as baclofen intrathecally to treat chronic intractable spasticity in people who have proven unresponsive to less invasive medical therapy. It also covers opioid drugs for the treatment of chronic intractable pain.
Further, the report states that one challenge that could hamper market growth is the limited number of approved medications that can be administered through intrathecal pumps.
- Codman & Shurtleff
- Flowonix Medical
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Cost analysis
PART 06: Market landscape
PART 07: Market segmentation by application
PART 08: Market segmentation by drug type
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Key vendor analysis
For more information visit http://www.researchandmarkets.com/research/r867l4/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets